VERNAL KERATOCONJUNCTIVITIS;

Purpose: To find out safety and effectiveness of supratarsal injection of Triamcinolone in cobble stone papilla e in VernalKeratoconjunctivitis (VKC). Design: Prospective, uncontrolled trial. Period: June 2009 to January 2010. Setting: Department ofOphthalmology KMU Institute Of Medical Sciences Hospital KDA Kohat. Material and Methods: One hundred and fifty diagnosed patientsof VKC, of both sexes and age group between 5 – 40 years were included in the study. Patients with glaucoma, or steroid responder, postherpeticcorneal scar, active infection of cornea or conjunctiva, tightly closed eyelids, patients who lost follow-up, and patients unwillingto be enrolled in this study were excluded from the study. The patients were enrolled and informed consent was taken. Supratarsalinjection of Triamcinolone was given. Their record was maintained and all the patients were followed up for six months for evaluating theireffectiveness and side effects. Results: We treated two hundred and seventy five eyes of one hundred fifty patients. Among them 80%were males. Mean age was 14 years (range: 5—40 years). All of the patients had itching of eyes, redness, watering, photophobia,cobble-stone papillae and Tranta's dots. Mean duration of disease was 27 weeks (Range: 4 weeks to 10 months). Patients were followedup and multiple injections were given for controlling disease. Transient redness was the most common side effect of injection therapy.Study shows 100% effectiveness of supratarsal injection of triamcinolone acetonide in VKC although